NCT06234410 Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
| NCT ID | NCT06234410 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Edinburgh |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 332 participants |
| Start Date | 2024-01-24 |
| Primary Completion | 2032-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 332 participants in total. It began in 2024-01-24 with a primary completion date of 2032-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular disease (for example, heart attack, stroke, heart failure) is the commonest complication of kidney failure. Kidney transplantation reduces cardiovascular risk but cardiovascular disease remains the commonest cause of death in patients following transplantation. Current strategies to assess patient's cardiovascular risk prior to kidney transplantation do not identify those at highest risk and do not improve outcomes. This study will use a heart scan known as computed tomography coronary angiography (CTCA) to see whether this scan can identify patients at highest risk of future cardiovascular disease prior to transplantation. Studies have shown it is able to do this in patients with normal kidney function. The aim of this study is to develop CTCA as an effective tool to risk stratify patients prior to kidney transplantation.
Eligibility Criteria
Inclusion Criteria: * Has kidney failure and is on the waitlist for a kidney transplant * Age 16 years and over * Able to give informed consent Exclusion Criteria: * Contraindication to CT scanning, including contrast allergy * Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation * Inability to give informed consent
Contact & Investigator
Neeraj Dhaun, MBChB
PRINCIPAL INVESTIGATOR
University of Edinburgh
Frequently Asked Questions
Who can join the NCT06234410 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06234410 currently recruiting?
Yes, NCT06234410 is actively recruiting participants. Contact the research team at gchapma2@ed.ac.uk for enrollment information.
Where is the NCT06234410 trial being conducted?
This trial is being conducted at Edinburgh, United Kingdom, Glasgow, United Kingdom.
Who is sponsoring the NCT06234410 clinical trial?
NCT06234410 is sponsored by University of Edinburgh. The principal investigator is Neeraj Dhaun, MBChB at University of Edinburgh. The trial plans to enroll 332 participants.